Table 1 Thrombosis and bleeding in CLL patients during hospitalization for severe COVID-19
n/N | 95% CI | |
|---|---|---|
Thrombosis overall* | 51/460 (0.11) | 0.08–0.14 |
Pulmonary embolism | 37/51 | |
Deep vein thrombosis | 7/51 | |
Ischaemic stroke | 5/51 | |
Myocardial infarction | 2/51 | |
Line associated thrombosis | 1/51 | |
Pernio-like skin lesions | 1/51 | |
Thrombosis-related death | 19/460 (0.04) | 0.02–0.06 |
Bleeding overall | 23/468 (0.05) | 0.03–0.07 |
Major | 12/23 | |
Gastrointestinal | 6/12 | |
CNS/haemorrhagic stroke | 3/12 | |
Intramuscular | 3/12 | |
Minor* | 11/23 | |
Epistaxis | 5/11 | |
Skin | 4/11 | |
Genitourinary | 2/11 | |
Gastrointestinal | 1/11 | |
Conjuctival | 1/11 |